Dose–Exposure–Response Analysis of Finerenone on Serum Potassium and Cardiovascular Outcomes Among Patients With Heart Failure: Insights From <scp>FINEARTS</scp> ‐ <scp>HF</scp>

Thomas Eissing, Finnian R. Mc Causland, Muthiah Vaduganathan, Sebastiaan C. Goulooze, Eleonora Marostica, Jan Berkhout, Paul van den Berg, Nelleke Snelder, Dirk Garmann, Joerg Lippert, Meike Brinker, Brian L. Claggett, John J. V. McMurray, Scott D. Solomon

Open source

DOI: 10.1111/dom.71493
Published: 2026-11-03
Container: Diabetes, Obesity and Metabolism
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/dom.71493,
  title = {Dose–Exposure–Response Analysis of Finerenone on Serum Potassium and Cardiovascular Outcomes Among Patients With Heart Failure: Insights From
                    <scp>FINEARTS</scp>
                    ‐
                    <scp>HF</scp>},
  author = {Thomas Eissing and Finnian R. Mc Causland and Muthiah Vaduganathan and Sebastiaan C. Goulooze and Eleonora Marostica and Jan Berkhout and Paul van den Berg and Nelleke Snelder and Dirk Garmann and Joerg Lippert and Meike Brinker and Brian L. Claggett and John J. V. McMurray and Scott D. Solomon},
  year = {2026},
  journal = {Diabetes, Obesity and Metabolism},
  doi = {10.1111/dom.71493},
  url = {https://doi.org/10.1111/dom.71493}
}

RIS

TY  - JOUR
TI  - Dose–Exposure–Response Analysis of Finerenone on Serum Potassium and Cardiovascular Outcomes Among Patients With Heart Failure: Insights From
                    <scp>FINEARTS</scp>
                    ‐
                    <scp>HF</scp>
AU  - Thomas Eissing
AU  - Finnian R. Mc Causland
AU  - Muthiah Vaduganathan
AU  - Sebastiaan C. Goulooze
AU  - Eleonora Marostica
AU  - Jan Berkhout
AU  - Paul van den Berg
AU  - Nelleke Snelder
AU  - Dirk Garmann
AU  - Joerg Lippert
AU  - Meike Brinker
AU  - Brian L. Claggett
AU  - John J. V. McMurray
AU  - Scott D. Solomon
PY  - 2026
JO  - Diabetes, Obesity and Metabolism
DO  - 10.1111/dom.71493
UR  - https://doi.org/10.1111/dom.71493
ER  -

APA

Eissing, T., Causland, F. R. M., Vaduganathan, M., Goulooze, S. C., Marostica, E., Berkhout, J., Berg, P. V. D., Snelder, N., Garmann, D., Lippert, J., Brinker, M., Claggett, B. L., McMurray, J. J. V., & Solomon, S. D. (2026). Dose–Exposure–Response Analysis of Finerenone on Serum Potassium and Cardiovascular Outcomes Among Patients With Heart Failure: Insights From <scp>FINEARTS</scp> ‐ <scp>HF</scp>. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71493

Source records

crossref · retrieved 2026-11-05T13:02:25.501Z